InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,631.22
(
0.28%
)
US TECH 100
19,886.40
(
0.47%
)
Dow Jones
40,211.72
(
0.53%
)
Brent Oil
84.34
(
-0.30%
)
Bitcoin
64,645.00
(
6.36%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Canadian Trader

Send PM Follow Ignore
Followers 29
Posts 720
Boards Moderated 0
Alias Born 01/22/2014

Canadian Trader

Re: d5wr59mfi8 post# 132648

Tuesday, 05/13/2014 5:28:45 PM

Tuesday, May 13, 2014 5:28:45 PM

Post# of 158400
Agreed. FDA approval news would be THE BIG ONE to see BMSN and Regen* rocket away. It's been said before here that that event will be the "make or break" for this stock, and based on the current DD available, it's looking as if it's leaning far towards the "make" side!


* - In the event of FDA approval for clinical trials of HemaXellerate, I'm hoping the announcement is aligned with the Regen BioPharma IPO for maximum impact.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up